Mesopancreas Study in Pancreatic Cancer

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHeinrich-Heine University, Duesseldorf

About this trial

After the Introduction of the pathological circumferential resection margin (CRM status by LEEPP Protocol), residual cancer (R1 resection) was most often found in the dorsal and medial resection margins. Yet only the medial resection margin is preoperatively evaluated during staging, while the dorsal resection margin which embeds the mesopancreatic fat and thus resembles the area of the mesopancreas, is not considered during preoperative assessment for resectability. Local recurrence is similarly prevalent as systemic relapse, and revised lower rates of R0CRM- resections through the LEEPP protocol explained the poor local tumor control. The aim of this study is to interdisciplinary approach the circumferential infiltration status of the PDAC concentrating foremost on the mesopancreas of the dorsal resection margin by including anatomic and embryologic derived perspectives.

Eligibility criteria

Qualifiers

All patients age ≥18 years who are admitted for primary surgery or patients who Received neoadjuvant therapy prior to surgery

CRM analysis through Pathologic Institute in study centre already implemented (see LEEPP protocol Menon et al (2009) Impact of margin status on survival following pancreatoduodenectomy for cancer: the Leeds Pathology Protocol (LEEPP). HPB 11(1):18-24)

Preoperative computed-tomographic Imaging (biphasic) prior to surgery (if resected without neoadjuvant treatment)

Pre-chemotherapeutic computed-tomographic and post-chemotherapeutic computed-tomographic if neoadjuvantly treated (biphasic).

Disqualifiers

Palliation

Abort of operative procedure

No preoperative computed-tomography for staging

No pathological CRM Implementation according to the LEEPP

Trial design

Treatments tested in this trial

  • oncological relevance of the mesopancreas

Treatment groups

500 Participants
are divided into 2 treatment groups